70 related articles for article (PubMed ID: 11503820)
1. Neurological disorders after zidovudine exposure in utero.
Prescrire Int; 1999 Dec; 8(44):181-2. PubMed ID: 11503820
[TBL] [Abstract][Full Text] [Related]
2. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
[TBL] [Abstract][Full Text] [Related]
3. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.
Blanche S; Tardieu M; Rustin P; Slama A; Barret B; Firtion G; Ciraru-Vigneron N; Lacroix C; Rouzioux C; Mandelbrot L; Desguerre I; Rötig A; Mayaux MJ; Delfraissy JF
Lancet; 1999 Sep; 354(9184):1084-9. PubMed ID: 10509500
[TBL] [Abstract][Full Text] [Related]
4. Zidovudine administration during pregnancy and mitochondrial disease in the offspring.
Tovo PA; Chiapello N; Gabiano C; Zeviani M; Spada M
Antivir Ther; 2005; 10(6):697-9. PubMed ID: 16218167
[TBL] [Abstract][Full Text] [Related]
5. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction following perinatal exposure to nucleoside analogues.
Blanche S; Tardieu M; Benhammou V; Warszawski J; Rustin P
AIDS; 2006 Aug; 20(13):1685-90. PubMed ID: 16931932
[No Abstract] [Full Text] [Related]
7. Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors.
Walker VE; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):159-65. PubMed ID: 17358025
[No Abstract] [Full Text] [Related]
8. Altered heterochromatin organization after perinatal exposure to zidovudine.
Senda S; Blanche S; Costagliola D; Cibert C; Nigon F; Firtion G; Floch C; Parat S; Viegas-Péquignot E
Antivir Ther; 2007; 12(2):179-87. PubMed ID: 17503660
[TBL] [Abstract][Full Text] [Related]
9. Effects of prenatal exposure to Zidovudine and Lamivudine on brainstem auditory evoked potentials in infants from HIV-infected women.
Poblano A; Figueroa L; Figueroa-Damián R; Schnaas L
Proc West Pharmacol Soc; 2004; 47():46-9. PubMed ID: 15633610
[TBL] [Abstract][Full Text] [Related]
10. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.
Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F;
Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945
[TBL] [Abstract][Full Text] [Related]
11. Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: Results from population-based surveillance in six provinces.
Plipat T; Naiwatanakul T; Rattanasuporn N; Sangwanloy O; Amornwichet P; Teeraratkul A; Ungchusak K; Mock P; Levine W; McConnell MS; Simonds R; Culnane M
AIDS; 2007 Jan; 21(2):145-51. PubMed ID: 17197804
[TBL] [Abstract][Full Text] [Related]
12. Uptake of interventions, outcomes and challenges in caring for HIV-exposed infants in Kingston, Jamaica.
Steel-Duncan JC; Pierre R; Evans-Gilbert T; Rodriquez B; Smikle MF; Palmer P; Whorms S; Hambleton I; Figueroa JP; Christie CD
West Indian Med J; 2004 Oct; 53(5):308-14. PubMed ID: 15675496
[TBL] [Abstract][Full Text] [Related]
13. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
Alimenti A; Burdge DR; Ogilvie GS; Money DM; Forbes JC
Pediatr Infect Dis J; 2003 Sep; 22(9):782-9. PubMed ID: 14506368
[TBL] [Abstract][Full Text] [Related]
14. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
Panburana P; Sirinavin S; Phuapradit W; Vibhagool A; Chantratita W
Am J Obstet Gynecol; 2004 Mar; 190(3):803-8. PubMed ID: 15042018
[TBL] [Abstract][Full Text] [Related]
15. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
American Academy of Pediatrics Committee on Pediatric AIDS
Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
[TBL] [Abstract][Full Text] [Related]
16. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
[TBL] [Abstract][Full Text] [Related]
17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
18. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
Koh MT
Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
[No Abstract] [Full Text] [Related]
19. Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir.
Divi RL; Walker VE; Wade NA; Nagashima K; Seilkop SK; Adams ME; Nesel CJ; O'Neill JP; Abrams EJ; Poirier MC
AIDS; 2004 Apr; 18(7):1013-21. PubMed ID: 15096804
[TBL] [Abstract][Full Text] [Related]
20. Is mama a criminal? An analysis of potential criminal liability of HIV-infected pregnant women in the context of mandated drug therapy.
Ayers L
Drake Law Rev; 2002; 50(2):293-314. PubMed ID: 12680390
[No Abstract] [Full Text] [Related]
[Next] [New Search]
